Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Invex Therapeutics Ltd. ( (AU:IXC) ) just unveiled an update.
Invex Therapeutics Ltd has requested a trading halt on its securities pending a significant announcement regarding a material acquisition and a response to an ASX price query. This trading halt is expected to last until the announcement is released or normal trading resumes on 25 September 2025, potentially impacting the company’s market positioning and stakeholder interests.
More about Invex Therapeutics Ltd.
Invex Therapeutics Ltd is a company operating in the biotechnology industry, focusing on developing treatments for neurological conditions. The company is listed on the Australian Securities Exchange (ASX) under the ticker IXC.
Average Trading Volume: 51,691
Technical Sentiment Signal: Buy
Current Market Cap: A$7.89M
Learn more about IXC stock on TipRanks’ Stock Analysis page.